Sudeep Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 30-06-2024
- Paid Up Capital ₹ 1.41 Cr
as on 30-06-2024
- Company Age 34 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 132.19 Cr
as on 30-06-2024
- Satisfied Charges ₹ 21.21 Cr
as on 30-06-2024
- Revenue 59.33%
(FY 2022)
- Profit 49.50%
(FY 2022)
- Ebitda 48.92%
(FY 2022)
- Net Worth 45.12%
(FY 2022)
- Total Assets 55.82%
(FY 2022)
About Sudeep Pharma
The Corporate was formerly known as Sudeep Pharma Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 1.41 Cr.
The company currently has active open charges totaling ₹132.19 Cr. The company has closed loans amounting to ₹21.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shanil Bhayani, Sujit Bhayani, Nils Gersonde, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1989PTC013141
- Company No.
013141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 1989
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sudeep Pharma Private Limited offer?
Sudeep Pharma Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Flavours & Aromatics, Bakery & Confectionery Flavors, Industrial Chemicals & Supplies, Industrial Chemicals, Food Additive, Organic Salt, Dyes & Color Additives, White Pigments.
Who are the key members and board of directors at Sudeep Pharma?
Executive Team (1)
Sujit Bhayani
Managing DirectorAppointment Date: 01-Mar-1995
Status: Current
Board Members(3)
Financial Performance and Corporate Structure Insights of Sudeep Pharma.
Sudeep Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.33% increase. The company also saw a substantial improvement in profitability, with a 49.5% increase in profit. The company's net worth Soared by an impressive increase of 45.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sudeep Pharma?
In 2023, Sudeep Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jrs Pharma & Gujarat Microwax Private Limited
Active
35 years 8 months Nils Gersonde and Dr Hempe are mutual person
Sudeep Nutrition Private Limited
Active 4 years 16 days Shanil Bhayani, Sujit Bhayani and 2 more are mutual person
Star Pharmchem International Llp
Active 1 year 6 months Shanil Bhayani and Sujit Bhayani are mutual person
Sudeep Advanced Materials Private Limited
Active 1 month 6 days Shanil Bhayani and Sujit Bhayani are mutual person
Riva Resources Private Limited
Active 8 months 21 days Shanil Bhayani and Sujit Bhayani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jan 2022 | ₹60.69 Cr | Open |
Citi Bank N.A. Creation Date: 29 Sep 2020 | ₹20.00 Cr | Open |
Citi Bank N.A. Creation Date: 20 Aug 2019 | ₹6.50 Cr | Open |
How Many Employees Work at Sudeep Pharma?
Sudeep Pharma has a workforce of 377 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Oct 26, 2015, Sudeep Pharma has raised a total of ₹ 10 Cr, with the most recent deal valued at ₹ 10 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
